CoChat
Sign Up
Cited by 70

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Mechanism of human somatic reprogramming to iPS cell

Teshigawara, Rika, Cho, Junkwon, Kameda, Masahiro, Tada, Takashi·2017·Laboratory Investigation
DOI 10.1038/labinvest.2017.56
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/labinvest.2017.56

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 58

  1. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  2. Hochedlinger, 2009, Epigenetic reprogramming and induced pluripotency, Development, 136, 509, 10.1242/dev.020867 · DOI
  3. Takahashi, 2007, Induction of pluripotent stem cells from fibroblast cultures, Nat Protoc, 2, 3081, 10.1038/nprot.2007.418 · DOI
  4. Lowry, 2008, Generation of human induced pluripotent stem cells from dermal fibroblasts, Proc Natl Acad Sci USA, 105, 2883, 10.1073/pnas.0711983105 · DOI · Paper page
  5. Hussein, 2012, Progress made in the reprogramming field: new factors, new strategies and a new outlook, Curr Opin Genet Dev, 22, 435, 10.1016/j.gde.2012.08.007 · DOI
  6. Zhou, 2009, Generation of induced pluripotent stem cells using recombinant proteins, Cell Stem Cell, 4, 381, 10.1016/j.stem.2009.04.005 · DOI · Paper page
  7. Li, 2014, Generation of pluripotent stem cells via protein transduction, Int J Dev Biol, 58, 21, 10.1387/ijdb.140007XL · DOI
  8. Zhou, 2013, Integration-free methods for generating induced pluripotent stem cells, Genomics Proteomics Bioinformatics, 11, 284, 10.1016/j.gpb.2013.09.008 · DOI
  9. Singh, 2015, Mechanism of induction: induced pluripotent, J Stem Cells, 10, 43
  10. Schlaeger, 2015, A comparison of non-integrating reprogramming methods, Nat Biotechnol, 33, 58, 10.1038/nbt.3070 · DOI
  11. Higuchi, 2015, Generation of pluripotent stem cells without the use of genetic material, Lab Invest, 95, 26, 10.1038/labinvest.2014.132 · DOI
  12. Buganim, 2012, Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase, Cell, 150, 1209, 10.1016/j.cell.2012.08.023 · DOI · Paper page
  13. Wernig, 2008, Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease, Proc Natl Acad Sci USA, 105, 5856, 10.1073/pnas.0801677105 · DOI
  14. Nagata, 2009, Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells, Genes Cells, 14, 1395, 10.1111/j.1365-2443.2009.01356.x · DOI
  15. Polo, 2010, Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells, Nat Biotechnol, 28, 848, 10.1038/nbt.1667 · DOI
  16. Stadtfeld, 2010, Induced pluripotency: history, mechanisms, and applications, Genes Dev, 24, 2239, 10.1101/gad.1963910 · DOI
  17. Brambrink, 2008, Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells, Cell Stem Cell, 2, 151, 10.1016/j.stem.2008.01.004 · DOI
  18. David, 2014, Phases of reprogramming, Stem Cell Res, 12, 754, 10.1016/j.scr.2014.03.007 · DOI · Paper page
  19. Silva, 2009, Nanog is the gateway to the pluripotent ground state, Cell, 138, 722, 10.1016/j.cell.2009.07.039 · DOI · Paper page
  20. Nefzger, 2014, Cell surface marker mediated purification of iPS cell intermediates from a reprogrammable mouse model, J Vis Exp, 91, e51728
  21. Samavarchi-Tehrani, 2010, Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming, Cell Stem Cell, 7, 64, 10.1016/j.stem.2010.04.015 · DOI · Paper page
  22. Esteban, 2012, The mesenchymal-to-epithelial transition in somatic cell reprogramming, Curr Opin Genet Dev, 22, 423, 10.1016/j.gde.2012.09.004 · DOI
  23. Leonardo, 2012, The functions of microRNAs in pluripotency and reprogramming, Nat Cell Biol, 14, 1114, 10.1038/ncb2613 · DOI
  24. Park, 2017, Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts, PLoS ONE, 12, e0171300, 10.1371/journal.pone.0171300 · DOI
  25. Krause, 2016, Understanding the molecular mechanisms of reprogramming, Biochem Biophys Res Commun, 473, 693, 10.1016/j.bbrc.2015.11.120 · DOI
  26. Boward, 2016, Concise review: control of cell fate through cell cycle and pluripotency networks, Stem Cells, 34, 1427, 10.1002/stem.2345 · DOI
  27. Wang, 2013, Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation, Proc Natl Acad Sci USA, 110, 2858, 10.1073/pnas.1212769110 · DOI · Paper page
  28. Li, 2010, A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts, Cell Stem Cell, 7, 51, 10.1016/j.stem.2010.04.014 · DOI · Paper page
  29. Mikkelsen, 2008, Dissecting direct reprogramming through integrative genomic analysis, Nature, 454, 49, 10.1038/nature07056 · DOI
  30. Sridharan, 2008, Illuminating the black box of reprogramming, Cell Stem Cell, 2, 295, 10.1016/j.stem.2008.03.015 · DOI
  31. Polo, 2010, When fibroblasts MET iPSCs, Cell Stem Cell, 7, 5, 10.1016/j.stem.2010.05.018 · DOI
  32. Lamouille, 2013, Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs, Curr Opin Cell Biol, 25, 200, 10.1016/j.ceb.2013.01.008 · DOI
  33. Wang, 2011, The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependentmanner, Cell Stem Cell, 9, 575, 10.1016/j.stem.2011.10.005 · DOI · Paper page
  34. Onder, 2012, Chromatin-modifying enzymes as modulators of reprogramming, Nature, 483, 598, 10.1038/nature10953 · DOI
  35. Chia, 2010, A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity, Nature, 468, 316, 10.1038/nature09531 · DOI
  36. Hanna, 2010, Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs, Proc Natl Acad Sci USA, 107, 9222, 10.1073/pnas.1004584107 · DOI
  37. Hirano, 2012, Human and mouse induced pluripotent stem cells are differentially reprogrammed in response to kinase inhibitors, Stem Cells Dev, 21, 1287, 10.1089/scd.2011.0283 · DOI
  38. Pasque, 2015, X chromosome reactivation in reprogramming and in development, Curr Opin Cell Biol, 37, 75, 10.1016/j.ceb.2015.10.006 · DOI
  39. Gafni, 2013, Derivation of novel human ground state naive pluripotent stem cells, Nature, 504, 282, 10.1038/nature12745 · DOI
  40. Guo, 2009, Klf4 reverts developmentally programmed restriction of ground state pluripotency, Development, 136, 1063, 10.1242/dev.030957 · DOI
  41. Gu, 2016, Pluripotency-associated miR-290/302 family of microRNAs promote the dismantling of naive pluripotency, Cell Res, 26, 350, 10.1038/cr.2016.2 · DOI
  42. Boyer, 2005, Core transcriptional regulatory circuitry in human embryonic stem cells, Cell, 122, 947, 10.1016/j.cell.2005.08.020 · DOI · Paper page
  43. Collier, 2017, Comprehensive Cell Surface Protein Profiling Identifies Specific Markers of Human Naive and Primed Pluripotent States, Cell Stem Cell, 20, 874-890.e7, 10.1016/j.stem.2017.02.014 · DOI
  44. Theunissen, 2011, Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions, Curr Biol, 21, 65, 10.1016/j.cub.2010.11.074 · DOI
  45. Chen, 2013, H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs, Nat Genet, 45, 34, 10.1038/ng.2491 · DOI · Paper page
  46. Nishimura, 2014, Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming, Stem Cell Rep, 3, 915, 10.1016/j.stemcr.2014.08.014 · DOI
  47. Nagata, 2012, Self-renewal and pluripotency acquired through somatic reprogramming to human cancer stem cells, PLoS ONE, 7, e48699, 10.1371/journal.pone.0048699 · DOI
  48. Park, 2017, Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells, Stem Cells and Development, 26, 734, 10.1089/scd.2016.0320 · DOI
  49. Teshigawara, 2016, OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition, Development, 143, 15
  50. Frisa, 2002, Cell density related gene expression: SV40 large T antigen levels in immortalized astrocyte lines, BMC Cell Biol, 3, 10, 10.1186/1471-2121-3-10 · DOI
  51. Yamanaka, 2009, Elite and stochastic models for induced pluripotent stem cell generation, Nature, 460, 49, 10.1038/nature08180 · DOI
  52. Greder, 2012, Analysis of endogenous Oct4 activation during induced pluripotent stem cell reprogramming using an inducible Oct4 lineage label, Stem Cells, 30, 2596, 10.1002/stem.1216 · DOI
  53. Silva, 2008, Promotion of reprogramming to ground state pluripotency by signal inhibition, PLoS Biol, 6, e253, 10.1371/journal.pbio.0060253 · DOI
  54. Tonge, 2014, Divergent reprogramming routes lead to alternative stem-cell states, Nature, 516, 192, 10.1038/nature14047 · DOI
  55. Jackson, 2016, Alternative routes to induced pluripotent stem cells revealed by reprogramming of the neural lineage, Stem Cell Rep, 6, 302, 10.1016/j.stemcr.2016.01.009 · DOI
  56. Ohgushi, 2011, Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states, Trends Cell Biol, 21, 274, 10.1016/j.tcb.2011.02.004 · DOI
  57. Watanabe, 2007, A ROCK inhibitor permits survival of dissociated human embryonic stem cells, Nat Biotechnol, 25, 681, 10.1038/nbt1310 · DOI · Paper page
  58. Waddington, 2016, A Broad overview and review of CRISPR-Cas technology and stem cells, Curr Stem Cell Rep, 2, 9, 10.1007/s40778-016-0037-5 · DOI

Cited by

Sorted by citations

See all 70

Metadata

Authors
Teshigawara, R., Cho, J., Kameda, M., & Tada, T.
Venue
Laboratory Investigation
Publisher
Elsevier BV
Published
2017-10
Volume
97
Issue
10
Pages
1152-1157
ISSN
0023-6837
DOI
10.1038/labinvest.2017.56
Cited by
70
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanism of human somatic reprogramming to iPS cell. https://app.cochat.ai/papers/10.1038/labinvest.2017.56
The paper
Teshigawara, R., Cho, J., Kameda, M., & Tada, T. (2017). Mechanism of human somatic reprogramming to iPS cell. Laboratory Investigation. https://doi.org/10.1038/labinvest.2017.56